Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Serum Free Light Chains
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravis | Neurology Neuroimmunology & Neuroinflammation
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis | Haematologica
Measuring M-Protein SPEP, UPEP Tests | Int'l Myeloma Fdn
Kappa and Lambda Light Chains - HealthTree for Myeloma
FLC Why choose the Sebia Free Light Chain (FLC) assay?
IJMS | Free Full-Text | The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
Free light chain (FLC) interactions with neutrophils. in vitro... | Download Scientific Diagram
Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemia | Haematologica
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
Serum Free Light Chains
Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS | PLOS ONE
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
TECHNICALREVIEW
